Kenneth Carl Anderson
Director · 5 filings · Latest: Oct 1, 2026
C4 Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
CCCC | Kenneth Carl Anderson | Director | Jun 1, 2026 | Option Exercise | $2.11 | 1,070 | $2.3K | 69,300 |